Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road.

Malecela MN, Mwingira U, Mwakitalu ME, Kabali C, Michael E, Mackenzie CD.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S53-7. doi: 10.1179/000349809X12502035776676.

PMID:
19843398
2.

Lymphatic filariasis: patients and the global elimination programme.

Mackenzie CD, Lazarus WM, Mwakitalu ME, Mwingira U, Malecela MN.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S41-51. doi: 10.1179/000349809X12502035776630.

PMID:
19843397
3.

The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).

Hooper PJ, Bradley MH, Biswas G, Ottesen EA.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S17-21. doi: 10.1179/000349809X12502035776513.

PMID:
19843394
4.

Current status and future prospects of the Global Lymphatic Filariasis Programme.

Molyneux DH, Taylor MJ.

Curr Opin Infect Dis. 2001 Apr;14(2):155-9. Review.

PMID:
11979126
5.

Diagnostic tools for filariasis elimination programs.

Weil GJ, Ramzy RM.

Trends Parasitol. 2007 Feb;23(2):78-82. Review.

PMID:
17174604
6.

Pacific collaboration to eliminate lymphatic filariasis.

Ichimori K, Crump A.

Trends Parasitol. 2005 Oct;21(10):441-4. Review.

PMID:
16099721
7.

Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.

Mohammed KA, Molyneux DH, Albonico M, Rio F.

Trends Parasitol. 2006 Jul;22(7):340-4. Review.

PMID:
16713740
9.

GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.

Gustavsen KM, Bradley MH, Wright AL.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S11-5. doi: 10.1179/000349809X12502035776478.

PMID:
19843393
10.

Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.

Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW.

Trends Parasitol. 2006 Nov;22(11):529-35.

PMID:
16971182
11.

Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.

Wamae CN, Mwandawiro C, Wambayi E, Njenga S, Kiliku F.

East Afr Med J. 2001 Nov;78(11):595-603.

PMID:
12219966
12.
13.

The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA.

PLoS Negl Trop Dis. 2010 Jun 1;4(6):e708. doi: 10.1371/journal.pntd.0000708.

16.

Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.

Showkath AM, Regu K, Rajendran R, Mohanan MK, Ganesh B.

J Commun Dis. 2008 Mar;40(1):37-40.

PMID:
19127667
17.

The development of albendazole for lymphatic filariasis.

Horton J.

Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S33-40. doi: 10.1179/000349809X12502035776595. Review.

PMID:
19843396
18.

Lymphatic filariasis: new insights into an old disease.

Melrose WD.

Int J Parasitol. 2002 Jul;32(8):947-60. Review.

PMID:
12076624
19.

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.

Plaisier AP, Stolk WA, van Oortmarssen GJ, Habbema JD.

Parasitol Today. 2000 Jul;16(7):298-302. Review.

PMID:
10858649
20.

Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.

Sunish IP, Shriram AN, Sivan A, Kartick C, Saha BP, Vijayachari P.

Trop Doct. 2013 Jan;43(1):30-2. doi: 10.1177/0049475513482123.

PMID:
23550201
Items per page

Supplemental Content

Support Center